Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/10768
Full metadata record
DC FieldValueLanguage
dc.contributor.authorErdoğan, Çağdaş-
dc.contributor.authorOngun, Nedim-
dc.contributor.authorTümkaya, Selim-
dc.contributor.authorAlkan, Hakan-
dc.contributor.authorÖztürk, Neşe-
dc.date.accessioned2019-08-16T13:32:52Z
dc.date.available2019-08-16T13:32:52Z
dc.date.issued2018-
dc.identifier.issn0019-1442-
dc.identifier.urihttps://hdl.handle.net/11499/10768-
dc.identifier.urihttps://doi.org/10.18071/isz.71.0213-
dc.description.abstractObjectives - Depression and anxiety are frequent in patients with chronic diseases such as diabetic neuropathic pain.The pain seems to be more severe in patients in whom depressive findings accompanied pain symptoms. Pregabalin was reported to have positive effects on anxiety and depression. This brings out the question, whether the pain relief effect of pregabalin is due to its analgesic effect or to its effects on mood? The aim of this study is to find out whether the positive effect of pregabalin in patients with diabetic neuropathic pain is limited to its effect on pain. Thus the question - do patients suffer from less pain or do they less care about pain? -should be answered. Methods - With this aim the NRS scores of 46 patients with diabetic neuropathic pain, whose HADS scores did not change with pregabalin treatment were compared with their baseline levels, retrospectively. Results - The NRS scores of the group were reduced with pregabalin treatment. Conclusion - This results suggests that the reduced pain in pregabalin treatment should be independent from its effects on depression and anxiety. © 2018 Ifjusagi Lap-es Konyvkiado Vallalat. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherIfjusagi Lap-es Konyvkiado Vallalaten_US
dc.relation.ispartofIdeggyogyaszati Szemleen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectDiabetic neuropathic painen_US
dc.subjectPregabalinen_US
dc.subjectanticonvulsive agenten_US
dc.subjectantidepressant agenten_US
dc.subjectpregabalinen_US
dc.subjectanalgesic agenten_US
dc.subjectadulten_US
dc.subjectanxiety disorderen_US
dc.subjectArticleen_US
dc.subjectcontrolled studyen_US
dc.subjectdepressionen_US
dc.subjectdiabetic neuropathyen_US
dc.subjectdiabetic patienten_US
dc.subjectdrug dose increaseen_US
dc.subjectdrug efficacyen_US
dc.subjectfemaleen_US
dc.subjectHospital Anxiety and Depression Scaleen_US
dc.subjecthumanen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectmiddle ageden_US
dc.subjectneuropathic painen_US
dc.subjectnon insulin dependent diabetes mellitusen_US
dc.subjectnumeric rating scaleen_US
dc.subjectpain assessmenten_US
dc.subjectpatient careen_US
dc.subjectretrospective studyen_US
dc.subjectrisk reductionen_US
dc.subjecttreatment responseen_US
dc.subjectanxietyen_US
dc.subjectdrug effecten_US
dc.subjectneuralgiaen_US
dc.subjectnociceptionen_US
dc.subjectpathophysiologyen_US
dc.subjectpsychologyen_US
dc.subjecttreatment outcomeen_US
dc.subjectAnalgesicsen_US
dc.subjectDiabetic Neuropathiesen_US
dc.subjectHumansen_US
dc.subjectNeuralgiaen_US
dc.subjectPain Perceptionen_US
dc.subjectRetrospective Studiesen_US
dc.subjectTreatment Outcomeen_US
dc.titleWhat is the real effect of pregabalin in patients with diabetic neuropathic pain? (do patients suffer from less pain or do they less care about it?)en_US
dc.typeArticleen_US
dc.identifier.volume71en_US
dc.identifier.issue5-6en_US
dc.identifier.startpage213
dc.identifier.startpage213en_US
dc.identifier.endpage216en_US
dc.authorid0000-0002-6231-7834-
dc.authorid0000-0001-8461-9131-
dc.identifier.doi10.18071/isz.71.0213-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid29889464en_US
dc.identifier.scopus2-s2.0-85049045415en_US
dc.identifier.wosWOS:000440959600008en_US
dc.identifier.scopusqualityQ4-
dc.ownerPamukkale University-
item.languageiso639-1en-
item.openairetypeArticle-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

1
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

1
checked on Jul 18, 2024

Page view(s)

32
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.